M&A Deal Summary |
|
|---|---|
| Date | 2023-02-16 |
| Target | East West Pharma Group |
| Sector | Medical Products |
| Buyer(s) | ECGI Holdings |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Medical Products |
| Employees | 1 |
ECGI Holdings is a developer of medical diagnostic equipment that focuses on the detection, and preventive treatment, of high-risk diseases. The Company’s core product isNowCardio, an advanced Advanced Ambulatory Arrhythmia Monitoring System monitor which offers the combined functionality of holter monitoring, event recording, and mobile cardiac telemetry simultaneously within in a single device. ECGI Holdings is headquartered in Los Angeles, United States.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: India M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-07-07 |
National Cardiac Monitoring Center
Glenelg, Maryland, United States National Cardiac Monitoring Center, Inc. is a FDA-registered independent diagnostic testing facility (IDTF), has been providing cardiac diagnostic services since 1986. It provides a range of cardiac monitoring modalities including Mobile Cardiac Telemetry (MCT), wireless and trans-telephonic cardiac event monitoring (CEM), 24/48-hour digital Holter monitoring with data transmission to NCMC, 24-hour ABP monitoring, full time and off-hours monitoring, and triage. The facility can receive any number of patient calls simultaneously, with patients receiving immediate, one-on-one service every time they call. NCMC will be used by EventCardio to introduce its NowCardio™ heart monitoring system in the U.S. upon clearance by the FDA and will serve as the Company’s U.S. data monitoring center. |
Buy | $5M |
